Conjugate of Bovine Hemoglobin and Human Serum Albumin as a Candidate for Blood Substitute: Characteristics and Effects on Rats

REFERENCES

• Baldwin, A.L., Wilson, L.M., Valeski, J.E. (1998). Ultrastructural effects of intravascularly injected polyethylene glycol-hemoglobin in intestinal mucosa. Am. J. Physiol. 275: H615–H625. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Chang, T.M.S. (1964). Semi-permeable microcapsules. Science 146: 524–525. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1997). Blood Substitues: Principle, Methods, Products and Clinical Trials.Karger Publisher 1–141, Basel. (www.medicine.mcgill.ca/artcell/1972bookCovercr.pdf).
   Google Scholar
• Chang, T.M.S. (2000). Red blood cell substitues. Best Pract. Res. Clin. Haematol 13: 651–668. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S., Varma, R. (1992). Effect of a single replacement of one of ringer lactate, hypertonic saline/Dextran, 7g% albumin, stroma-free hemoglobin, o-raffinose polyhemoglobin or whole blood on the long term survival of unanesthetized rates with lethal hemorrhagic shock after 67% acute blood loss. Biomat. Art. Cells & Immob. Biotech 20(2–4): 503–510. [CSA]
   PubMed Web of Science ®Google Scholar
• Cheng, D.C. (2001). Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery. Can J Anaesth 48(4 suppl): S41–48. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• D'Agnillo, F., Alayash, A.I. (2000). Site-specific modifications and toxicity of blood substitutes, the case of diaspirin cross-linked hemoglobin. Advanced Drug Delivery Reviews 40: 199–212. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Drabkin, D. (1949). The standardization of hemoglobin measurement. Am. J. Med. Sci 217: 710–711.
   PubMed Web of Science ®Google Scholar
• Dubrow, A., Flamenbaum, W. (1988). Acute renal failure associated with myoglobinuria and hemoglobinuria, inAcute Renal Failure, B.M. Brenner, J.M. Lazarus, Eds.,New York: Churchill Livingstone, 279–293
   Google Scholar
• Evelyn, K.A., Malloy, H.T. (1938). Microdetermination of oxyhemoglobin, methemoglobin, and sulfhemoglobin in a single sample of blood. J. Biol. Chem 126: 655–662.
   Google Scholar
• Flaim, S. (1997). Perflubron-based emulsion: efficacy as temporary oxygen carrier, inAdvances in Blood Substitutes, Industrial Opportunities and Medical Challenges, R.M. Winslow, K. Vandegriff, M. Intaglietta, Eds.,Boston: Brikhäuser.
   Google Scholar
• Hu, T., Su, Z.G. (2003). Solid phase adsorption method for preparation of bovine serum albumin-bovine hemoglobin conjugate. Journal of Biotechnology 100(3): 267–275. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Lu, X.L., Zhao, D.X., Su, Z.G. (2004). Purification of hemoglobin by ion exchange chromatography in flow-through mode with PEG as an escort. Artif. Cells, Blood Substit. and Biotechnol 32(2): 209–227. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Manning, L.R., Morgan, S., Beavis, R.C., Chait, B.T., Manning, J.M., Hess, J.R., Cross, M., Currell, D.L., Marini, M.A., Winslow, R.M. (1991). Preparation, properties, and plasma retention of human hemoglobin derivatives: comparison of uncrosslinked carboxymethylated hemoglobin with crosslinked tetrameric hemoglobin. Proc. Natl. Acad. Sci. USA 88(8): 3329–3333. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Palaparthy, R., Wang, H., Gulati, A. (2000). Current aspects in pharmacology of modified hemoglobins. Advanced Drug Delivery Reviews 40: 185–198. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Przybelski, R.J., Daily, E.K., Kisicki, J.C., Mattia-Goldberg, C., Bounds, M.J., Colburn, W.A. (1996). Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit. Care Med 24: 1993–2000. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sakai, H., Tsai, A.G., Rohlfs, R.J., Hara, H., Tsuchida, E., Intaglietta, M. (1999). Microvascular responses to hemodilution with Hb vesicles as red blood cell substitutes: influence of O2 affinity. Am J. Physiol 276(Heart Circ. Physiol.45): 553–562.
   PubMed Web of Science ®Google Scholar
• Sakai, H., Yuasa, M., Onuma, H., Takeoka, S., Tsuchida, E. (2000). Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: objective comparison between cellular and acellular types. Bioconjugate Chem. 11: 56–64. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schneeberger, E.E. (1988). Interaction of plasma proteins with negatively charged sites on the pulmonary capillary endothelium of the rat. Cell Tissue Res 251: 417–423. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Winslow, R.M. (2000). Blood substitutes. Advanced Drug Delivery Reviews 40: 131–142. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Winslow, R.W. (2003). Current status of blood substitute research: towards a new paradigm. Journal of Internal Medicine 253: 508–517. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Winslow, R.M. (1993). The toxicity of hemoglobin, in Hemoglobin-Based Red Blood Cell Substitutes,R.M. Winslow, Ed.,Baltimore: John Hopkins University Press, 136–163
   Google Scholar
• Winslow, R.M., Tsai, A.G., Vandergriff, K.D., Intaglietta, M. (2003). Targeted O2 delivery by low-P50 hemoglobin: a new basis for hemoglobin-based oxygen carriers. Artificial Blood 11(1): 45.
   Google Scholar